Laboratory:Hachioji
- TOP
- gene-related test
- genetic tests for malignant tumor (solid tumor)
Laboratory:Hachioji
○genetic tests for malignant tumor (solid tumor)
TEST NAME |
SPECIMEN REQUIREMENT (mL) |
CONTAINER | CAP COLOR | STORE TEMPERATURE (STABILITY) |
TURNAROUND TIME (DAY) |
METHODOLOGY | REFERENCE RANGE (UNIT) |
---|---|---|---|---|---|---|---|
BRAF V600 mutation analysis 〔PCR〕
|
Unstained specimen slide
5 to 10 sheets thickness 10μm |
Z10 |
|
4-10 |
PCR (Real Time PCR) Real-time PCR |
||
|
Unstained specimen slide
5 sheets thickness 5 to 10μm |
Z10 |
|
5-10 | PCR-rSSO method | ||
EGFR mutation analysis v2.0
|
Unstained specimen slide
5 to 10 sheets thickness 10μm |
Z10 |
|
3-6 |
PCR (Real Time PCR) Real-time PCR |
||
EGFR mutation analysis v2.0 (plasma)
|
Plasma
5.0 |
PK5,PK7 ↓ ARR |
|
3-6 |
PCR (Real Time PCR) Real-time PCR |
||
KRAS G12C mutation analysis
|
Unstained specimen slide
5 sheets thickness 5μm |
Z10 |
|
4-10 |
PCR (Real Time PCR) Real-time PCR |
||
IDH1/2 gene analysis (glioma) (FFPE)
|
Unstained specimen slide
5 to 10 sheets thickness 4 to 10μm |
Z10 |
|
11-14 |
Direct sequence method Direct sequencing method |
||
IDH1/2 gene analysis (glioma) (FF)
|
tissue
125mg |
ARR |
|
11-14 |
Direct sequence method Direct sequencing method |
||
c-kit gene mutation analysis (GIST)
|
tissue
250mg |
ARR |
|
11-23 |
Direct sequence method Direct sequencing method |
||
c-kit gene mutation analysis (GIST)
|
Unstained specimen slide *See below
|
Z10 |
|
11-23 |
Direct sequence method Direct sequencing method |
||
RAS/BRAF gene mutation analysis
|
Unstained specimen slide
5 sheets thickness 5 to 10μm |
Z10 |
|
4-7 | PCR-rSSO method | ||
|
Blood (Streck Cell-Free DNA BCT)
10.0 |
PCF |
|
5-7 | BEAMing method | ||
Microsatellite instability (MSI) testing (FFPE)
|
Unstained specimen slide
5 to 10 sheets thickness 5μm |
Z10 |
|
4-8 |
Multiplex PCR-fragment analysis After amplifying multiple target genes, the PCR amplification products are subjected to capillary electrophoresis using a sequencer. |
||
Microsatellite instability (MSI) testing (FF)
|
tissue
50mg |
ARR |
|
4-8 |
Multiplex PCR-fragment analysis After amplifying multiple target genes, the PCR amplification products are subjected to capillary electrophoresis using a sequencer. |
||
Lung Cancer Oncomine DxTT Multi 7 Gene CDxFFPE
|
Unstained specimen slide
5 to 10 sheets thickness 5μm |
Z10 |
|
6-9 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
tissue
100mg |
ARR |
|
6-9 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
Thyroid Cancer Oncomine DxTT Multi-2 Gene CDxFFPE
|
Unstained specimen slide
5 to 10 sheets thickness 5μm |
Z10 |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
tissue
100mg |
ARR |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
Lung Cancer Oncomine DxTT Multi 7 Gene CDx (46) FFPE
|
Unstained specimen slide
5 to 10 sheets thickness 5μm |
Z10 |
|
6-9 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
tissue
100mg |
ARR |
|
6-9 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
Thyroid Cancer Oncomine DxTT Multi-2 Gene CDx(46)FFPE
|
Unstained specimen slide
5 to 10 sheets thickness 5μm |
Z10 |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
tissue
100mg |
ARR |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
AmoyDx lung cancer multi-panel 7-gene IVD (3 months or less)
|
Unstained specimen slide
7 to 10 sheets thickness 5μm |
Z10 |
|
4-7 | PCR (real-time PCR), RT-PCR (real-time PCR) | ||
AmoyDx lung cancer multi-panel 7-gene IVD (3-12 months)
|
Unstained specimen slide
7 to 10 sheets thickness 5μm |
Z10 |
|
4-7 | PCR (real-time PCR), RT-PCR (real-time PCR) | ||
AmoyDx lung cancer multi-panel 7-gene IVD (12-24 months)
|
Unstained specimen slide
7 to 10 sheets thickness 5μm |
Z10 |
|
4-7 | PCR (real-time PCR), RT-PCR (real-time PCR) | ||
|
tissue
100mg |
ARR |
|
4-7 | PCR (real-time PCR), RT-PCR (real-time PCR) | ||
AmoyDx lung cancer multi-panel 7-gene (3 months or less)
|
Unstained specimen slide
7 to 10 sheets thickness 5μm |
Z10 |
|
4-7 | PCR (real-time PCR), RT-PCR (real-time PCR) | ||
AmoyDx lung cancer multi-panel 7-gene (3-12 months)
|
Unstained specimen slide
7 to 10 sheets thickness 5μm |
Z10 |
|
4-7 | PCR (real-time PCR), RT-PCR (real-time PCR) | ||
AmoyDx lung cancer multi-panel 7-gene (12-24 months)
|
Unstained specimen slide
7 to 10 sheets thickness 5μm |
Z10 |
|
4-7 | PCR (real-time PCR, RT-PCR (real-time PCR) | ||
|
tissue
100mg |
ARR |
|
4-7 | PCR (real-time PCR), RT-PCR (real-time PCR) | ||
Lung cancer compact panel (7 genes) CDx
|
Unstained specimen slide Thickness 5μm 5 to 10 sheets |
Z10 |
|
6-12 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
Lung cancer compact panel (7 genes) CDx
|
Frozen specimens (tissue and cytology)
1mg (1mm square) or more |
ARR |
|
6-12 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
Lung cancer compact panel (7 genes) CDx
|
Refrigerated specimen (cytology)
1mg (1mm square) or more |
X90 |
(14 days) |
6-12 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
Lung cancer compact panel (7 genes) for research
|
Unstained specimen slide Thickness 5μm 5 to 10 sheets |
Z10 |
|
6-12 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
Lung cancer compact panel (7 genes) for research
|
Frozen specimens (tissue and cytology)
1mg (1mm square) or more |
ARR |
|
6-12 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
Lung cancer compact panel (7 genes) for research
|
Refrigerated specimen (cytology)
1mg (1mm square) or more |
X90 |
(14 days) |
6-12 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide and Blood (EDTA-2K added) 5 sheets, thickness 10μm and 2.0 |
Z10 and PK2 |
|
16-22 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide and HE stained slide 10 sheets, thickness 4 to 5μm and 1 sheet |
Z10 |
|
16-19 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Blood (for cell-free DNA extraction)
17 |
PCD (Two) |
|
12-15 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Blood (Streck Cell-Free DNA BCT)
20.0 |
PCF(Two) Z90 |
|
16-18 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide and HE stained slide 8 sheets, thickness 5μm and 1 sheet |
Z10 |
|
18-23 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
bone marrow aspirate
1.0 |
H00 |
|
3-5 |
RT-PCR (Real Time PCR) Real-time PCR |
(copy/μgRNA) | |
|
Unstained specimen slide
|
Z10 |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
|
Z10 |
|
4-7 | PCR (real-time PCR) and RT-PCR (real-time PCR) | ||
|
Unstained specimen slide
|
Z10 |
|
4-6 | PCR-rSSO method | ||
|
tissue
|
ARR |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
15 pieces |
Z10 |
|
11-14 | Next Generation Sequencing (NGS) | ||
|
tissue
|
ARR |
(3 days) |
7-11 |
RT-PCR (Real Time PCR) Real-time PCR |
Not detected | |
|
Bronchial scraping lavage fluid sediment
|
ARR |
(3 days) |
7-11 |
RT-PCR (Real Time PCR) Real-time PCR |
Not detected | |
|
Alveolar lavage fluid sediment
|
ARR |
(3 days) |
7-11 |
RT-PCR (Real Time PCR) Real-time PCR |
Not detected | |
|
pleural fluid sediment
|
ARR |
(3 days) |
7-11 |
RT-PCR (Real Time PCR) Real-time PCR |
Not detected | |
|
Unstained specimen slide
15 pieces |
Z10 |
|
7-11 | Next Generation Sequencing (NGS) | ||
|
tissue
|
ARR |
|
7-11 | Next Generation Sequencing (NGS) | ||
|
tissue
|
ARR |
|
7-11 | Next Generation Sequencing (NGS) | ||
|
Unstained specimen slide
15 pieces |
Z10 |
|
7-11 | Next Generation Sequencing (NGS) | ||
|
Bronchial scraping lavage fluid sediment
|
ARR |
|
4-8 |
RT-PCR (Real Time PCR) Real-time PCR |
Negative | |
|
tissue
|
ARR |
|
12-16 |
Direct sequence method Direct sequence method |
||
|
Alveolar lavage fluid sediment
|
ARR |
|
4-8 |
RT-PCR (Real Time PCR) Real-time PCR |
Negative | |
|
tissue
100mg |
ARR |
|
4-8 |
RT-PCR (Real Time PCR) Real-time PCR |
Negative | |
|
pleural fluid sediment
|
ARR |
|
4-8 |
RT-PCR (Real Time PCR) Real-time PCR |
Negative | |
|
Unstained specimen slide
5 sheets thickness 5μm |
Z10 |
|
4-8 |
RT-PCR (Real Time PCR) Real-time PCR |
Negative | |
|
Unstained paraffin section
5 sheets |
ARR |
|
4-8 |
RT-PCR (Real Time PCR) Real-time PCR |
Negative | |
|
Unstained specimen slide *See below
|
Z10 |
|
11-14 |
Direct sequence method Direct sequencing method |
||
|
tissue
100mg |
ARR |
|
6-9 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
tissue
100mg |
ARR |
|
6-9 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
5-10 pieces 5μm |
Z10 |
|
6-9 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
5-10 pieces 5μm |
Z10 |
|
6-9 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Cytodiagnosis materials
1mg |
X90 |
(14 days) |
8-15 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
tissue
1mg |
ARR |
|
8-15 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
5-10 pieces 5μm |
Z10 |
|
8-15 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Cytodiagnosis materials
1mg |
X90 |
(14 days) |
8-15 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
tissue
1mg |
ARR |
|
8-15 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
5-10 pieces 5μm |
Z10 |
|
8-15 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
tissue
100mg |
ARR |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
5 to 10 sheets thickness 5?m |
Z10 |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
tissue
100mg |
ARR |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
5 to 10 sheets thickness 5?m |
Z10 |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide *See below
|
Z10 |
|
11-14 |
Direct sequence method Direct sequencing method |
||
|
Unstained specimen slide
5 to 10 sheets thickness 5 to 10?m |
Z10 |
|
4-7 |
PCR (Real Time PCR) Real-time PCR |
||
|
Blood (EDTA-2Na added)
7.0 |
PN7 |
|
3-5 |
RT-PCR (Real Time PCR) Real-time PCR |
(copy/μgRNA) | |
|
Blood (EDTA-2Na added)
7.0 |
PN7 |
|
3-5 |
RT-PCR (Real Time PCR) Real-time PCR |
(copy/μgRNA) | |
|
tissue
|
ARR |
|
4-7 | PCR (real-time PCR) and RT-PCR (real-time PCR) | ||
|
tissue
|
ARR |
|
11-14 | Next Generation Sequencing (NGS) | ||
|
tissue
|
ARR |
|
12-16 |
RT-PCR RT-PCR (Reverse transcriptase-polymerase chain reaction) |
Chimeric mRNA not detected | |
|
Unstained specimen slide
|
Z10 |
|
4-7 | PCR (real-time PCR) and RT-PCR (real-time PCR) | ||
|
tissue
|
ARR |
|
4-7 | PCR (real-time PCR) and RT-PCR (real-time PCR) | ||
|
tissue
|
ARR |
|
12-16 |
RT-PCR RT-PCR (Reverse transcriptase-polymerase chain reaction) |
Chimeric mRNA not detected | |
|
Plasma
5.0 |
↓ ARR |
|
4-10 |
PCR (Real Time PCR) Real-time PCR |
||
|
bone marrow aspirate
1.0 |
H00 |
|
3-5 |
RT-PCR (Real Time PCR) Real-time PCR |
(copy/μgRNA) | |
|
Unstained specimen slide
|
Z10 |
|
4-7 | PCR (real-time PCR) and RT-PCR (real-time PCR) | ||
|
Unstained specimen slide
|
Z10 |
|
8-14 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
|
Z10 |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
|
Z10 |
|
4-7 | PCR (real-time PCR) and RT-PCR (real-time PCR) | ||
|
tissue
|
ARR |
|
6-11 |
Next Generation Sequencing (NGS) A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments. |
||
|
Unstained specimen slide
|
Z10 |
|
4-7 | PCR (real-time PCR) and RT-PCR (real-time PCR) | ||
|
Unstained specimen slide
|
Z10 |
|
4-7 | PCR (real-time PCR) and RT-PCR (real-time PCR) |